(Q38078841)

28 August 2017

1 reference

title

Metabolomics in human type 2 diabetes research (English)

1 reference

28 August 2017

1 reference

1 reference

Jingyi Lu

1

1 reference

28 August 2017

Guoxiang Xie

series ordinal

2

1 reference

28 August 2017

Weiping Jia

series ordinal

3

1 reference

28 August 2017

Wei Jia

series ordinal

4

1 reference

28 August 2017

2 February 2013

1 reference

28 August 2017

Frontiers of medicine

1 reference

28 August 2017

7

1 reference

28 August 2017

4-13

1 reference

28 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11684-013-0248-4

28 August 2017

0 references

cites work

Metabolomics in diabetes research

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

The genetics of type 2 diabetes and its clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Insulin sensitivity is reflected by characteristic metabolic fingerprints--a Fourier transform mass spectrometric non-targeted metabolomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Metabonomic evaluation of melamine-induced acute renal toxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Analytical strategies in metabonomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Opening up the "Black Box": metabolic phenotyping and metabolome-wide association studies in epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

NMR-based plant metabolomics: where do we stand, where do we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Serum metabolic signatures of fulminant type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Postchallenge hyperglycemia in a national sample of U.S. adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Dyslipidemia in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Diabetic dyslipidaemia: from basic research to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Skeletal muscle fat oxidation: timing and flexibility are everything

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Exercise, MAPK, and NF-kappaB signaling in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Phosphatidylcholine biosynthesis and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Novel biomarkers for pre-diabetes identified by metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Plasma Amino Acid Levels and Insulin Secretion in Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Splanchnic glucose and amino acid metabolism in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

THE METABOLISM OF AMINO ACIDS IN DIABETES MELLITUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Metabolite profiles and the risk of developing diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Fast track to the porphyrias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

The presence of a transsulfuration pathway in the lens: a new oxidative stress defense system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Effects of diabetes mellitus on cholesterol metabolism in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

The effect of colesevelam hydrochloride on insulin sensitivity and secretion in patients with type 2 diabetes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Systemic gut microbial modulation of bile acid metabolism in host tissue compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Gut microorganisms, mammalian metabolism and personalized health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Role of the gut microbiota in defining human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

The Cardiovascular Risk of Healthy Individuals Studied by NMR Metabonomics of Plasma Samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0248-4

Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body

21 January 2018

1 reference

12 December 2020

Cross-platform comparison of methods for quantitative metabolomics of primary metabolism

1 reference

12 December 2020

The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes

1 reference

12 December 2020

Ketone body production and disposal: effects of fasting, diabetes, and exercise.

1 reference

12 December 2020

Time-dependent changes in the plasma amino acid concentration in diabetes mellitus

1 reference

12 December 2020

Reduction and recovery of plasma 1,5-anhydro-D-glucitol level in diabetes mellitus.

1 reference

12 December 2020

Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss.

1 reference

12 December 2020

Inflammatory mechanisms in the regulation of insulin resistance

1 reference

12 December 2020

The exogenous origin of trimethylamine in the mouse

1 reference

12 December 2020

Post-load glucose measurements in oral glucose tolerance tests correlate well with 1,5-anhydroglucitol, an indicator of overall glycaemic state, in subjects with impaired glucose tolerance

1 reference

12 December 2020

Proton nuclear magnetic resonance spectral profiles of urine in type II diabetic patients.

1 reference

12 December 2020

Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise

1 reference

12 December 2020

10.1007/S11684-013-0248-4

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference